Instructions to authors:
Gene Therapy and Molecular Biology (GTMB) get pdf version
|
Scope |
Gene Therapy and Molecular Biology, bridging various fields is one of the most rapid with free access at gtmb.org.
The scope of Gene Therapy and Molecular Biology is to promote interaction between researchers in the fields of Gene Therapy and Molecular Biology providing rapid publication of review articles and research papers. Articles, both invited and submitted, review or report novel findings of importance to a general audience in gene therapy, molecular medicine, gene discovery, and molecular biology with emphasis to molecular mechanisms. The journal will accept papers on all aspects of gene therapy including gene delivery systems, gene therapy of cancer and other diseases (e.g. CFTR, hemophilia, AIDS, restenosis) at the clinical, preclinical or cell culture stage, gene discovery, cancer immunotherapy, DNA vaccines, use of DNA regulatory elements in gene transfer, cell therapy and transplantation, arraying technologies & DNA chips, peptide libraries and drug discovery related to gene therapy, cell targeting, gene targeting, therapy with oligonucleotides (antisense, ribozymes, triplex). The authors are encouraged to elaborate on the molecular mechanisms that govern a gene therapy approach. Gene Therapy and Molecular Biology will also publish articles on, transcription factors, DNA replication, recombination, repair, chromatin, nuclear matrix, DNA regulatory regions, locus control regions, protein phosphorylation, signal transduction, development, and on molecular mechanism of human disease. To make the publication attractive authors are encouraged to include color figures.
|
Type of articles |
Both review and original research articles will be considered. In addition, short 1-2 page news & views will also be considered for publication. Original research articles should contain a generous introduction in addition to experimental data. The articles contain information important to a general audience as the volume is also addressed to researchers outside the field. There is no limit on the length of the articles provided that the subject is interesting to a general audience and covers exhaustively a field. The typical length of each manuscript is approximately 4-20 printed page including Figures and Tables, meaning 12-60 manuscript pages.
|
Charges, Complimentary reprints & Subscriptions |
There are no charges for color figures or number of pages submitted. Corresponding authors get a one-year free subscription (hard copy) plus 25 reprints free of charge. The free subscription can be renewed for additional years by having one paper per year accepted for publication The free electronic access to articles published in "Gene Therapy and Molecular Biology" to a big general audience, the attractive journal title, the speed of the reviewing process, the no-charges for number of pages or color figure reproduction, the 25 complimentary reprints, the rapid electronic publication, the embracing of many fields in gene therapy (from molecular mechanisms to clinical trials), the high quality in-depth reviews and first rate research articles, as well as (and most importantly) the eminent members of the Editorial Board being assembled, are prognostic factors of significant success for GTMB.
|
Sections of the manuscript |
Each manuscript should have a Title, Authors, Affiliation, Corresponding Author (with Tel, Fax, and E-mail), Summary, key words , running title and Introduction; review articles are subdivided into headings I, II, III, etc. (starting with I. Introduction) subdivided into A, B, C, and further subdivided using 1, 2, 3, etc. You can further subdivide into 1, 2, 3, etc. Research articles are divided into Summary; I. Introduction; II. Materials and Methods III. Results; IV. Discussion; Acknowledgments; and References. Please include in your text citations the name of authors and year in parenthesis; for three or more authors use: (name of first author et al, with year); for two authors please use both names. Please delete hidden text for references. In the reference list, please, type references with year and Journal in boldface and provide full title of the article such as:
Buschle M, Schmidt W, Berger M, Schaffner G, Kurzbauer R, Killisch I, Tiedemann J-K, Trska B, Kirlappos H, Mechtler K, Schilcher F, Gabler C, and Birnstiel ML (1998) Chemically defined, cell-free cancer vaccines: use of tumor antigen-derived peptides or polyepitope proteins for vaccination. Gene Ther Mol Biol 1, 309-321.
To avoid delays it is essential to submit an electronic and a hard copy version of your manuscript via e-mail and mail in a floppy, CD-ROM or ZIP, containing the manuscript that will be used to typeset the paper. Please include in the digital media: Tables, if any, (preferably as a Microsoft Word text) and Figure legends. Please use Microsoft Word, font ÒTimesÓ (Mac users) or ÒTimes New RomanÓ (PC users) and insert Greek or other characters using the ÒInsert/SymbolÓ function in the Microsoft Word rather than simple conversion to font ÒSymbolÓ. Please boldface Figure 1, 2, 3 etc. as well as Table 1, 2, etc. throughout the text. Please provide the highest quality of prints of your Figures; whenever possible, please provide in addition an electronic version of your figures.
Article contributors are kindly requested to provide a color (or
black/white) photo of themselves (preferably 4x5 cm or any size) or a group
photo of the authors, as we shall include these in the publication.
|
Reviewing
|
Peer reviewing is by members of the Editorial Board and external
referees. Please suggest 2-3 reviewers providing their electronic addresses,
mailing addresses and telephone/fax numbers.
Authors are sent page proofs.
Gene Therapy and Molecular Biology is published on high quality
paper, hardbound, and with excellent reproduction of color figures.
Reviewing is completed within 5-15 days from receiving the
manuscript.
Articles accepted without revisions (i.e., review articles) will
be published online (www.gtmb.org) in approximately 1 month following
submission.
|
Submission |
Please submit an electronic version of full text and figures,
preferably in jpeg format. The electronic version of the figures will be used
for the rapid reviewing process. High quality prints or photograph of the
figures and the original with one copy should be sent via express mail to the
Editorial Office.
By Mail:
Editorial Office
Gene Therapy & Molecular Biology
Cancer Therapy
Teni Boulikas, Ph.D., Editor and Publisher
Panagiotis Kourtesis, Ph.D., Managing Editor
Afxentiou 7
Alimos, Athens 17455
Greece
Tel: +30-210-9847-975
Fax: +30-210-9858-453
Electronically:
Panagiotis Kourtesis, Ph.D., Managing Editor
p.kourtesis@cancer-therapy.org
pikourtesis@regulon.org
Maria Vougiouka
maria@cancer-therapy.org
Adrian Kruit, Ph.D. (web content)
akruit@cancer-therapy.org
Assistants
Angela Ladopoulou, Ph.D.
angela.ladopoulou@cancer-therapy.org
Jenny Katsoupi, M.Sc.
jenny7@cancer-therapy.org
Submission and reviewing
|
Citation in MedLine |
Articles accepted for publication by GTMB or Cancer Therapy can be included in MedLine (PubMed) as full articles upon the request of authors provided that the authors have completed their published work under a government grant by NIH (or EU/Japan government grant). If this is you case, please consult the NIH Manuscript Submission System http://www.nihms.nih.gov/.
Gene Therapy and Molecular Biology
(GTMB) is covered in the following Thomson Scientific services:
Science Citation Index Expanded (also known as SciSearch)
Biotechnology Citation Index
Journals Citation Reports/Science Edition